RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Statement of Operations (Details) - USD ($) |
3 Months Ended | 5 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|---|---|---|
Sep. 30, 2020 |
Jun. 30, 2020 |
Mar. 31, 2020 |
Dec. 31, 2019 |
Jun. 30, 2021 |
Jun. 30, 2020 |
Sep. 30, 2020 |
Dec. 31, 2020 |
|
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Transaction costs allocable to warrant liabilities | $ (4,078) | $ (4,078) | ||||||
Change in fair value of warrant liability | $ (164,400) | $ (1,356,300) | $ 945,300 | (616,500) | (8,877,600) | $ (411,000) | $ (575,400) | $ (1,479,600) |
Net (Loss) Income | $ (224,706) | $ (1,301,788) | $ 1,291,894 | $ (378,919) | $ (11,284,061) | $ (9,894) | $ (234,600) | $ (1,531,192) |
Basic and diluted net loss per ordinary share, non-redeemable | $ (0.07) | $ (0.40) | $ 0.21 | $ (0.22) | $ (0.19) | $ (0.26) | $ (0.63) | |
Restatement Of Warrants As Derivative Liabilities | As Reported | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Net (Loss) Income | $ (60,306) | $ 54,512 | $ 346,594 | $ 241,659 | $ 401,106 | $ 340,800 | $ (51,592) | |
Basic and diluted net loss per ordinary share, non-redeemable | $ (0.30) | $ (0.02) | $ (0.06) | $ (0.05) | $ (0.08) | $ (0.10) | $ (0.22) | |
Restatement Of Warrants As Derivative Liabilities | Adjustment | ||||||||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | ||||||||
Transaction costs allocable to warrant liabilities | $ (4,078) | |||||||
Change in fair value of warrant liability | $ (164,400) | $ (1,356,300) | $ 945,300 | (616,500) | $ (411,000) | $ (575,400) | $ (1,479,600) | |
Net (Loss) Income | $ (164,400) | $ (1,356,300) | $ 945,300 | $ (620,578) | $ (411,000) | $ (575,400) | $ (1,479,600) | |
Basic and diluted net loss per ordinary share, non-redeemable | $ 0.23 | $ (0.38) | $ 0.27 | $ (0.17) | $ (0.11) | $ (0.16) | $ (0.41) |
X | ||||||||||
- Definition Amount of transaction costs allocable to warrant liabilities. No definition available.
|
X | ||||||||||
- Definition The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|